David A. Simon is a Lecturer on Law at Harvard Law School and a Research Fellow at the Petrie-Flom Center for Health Law Policy, Biotechnology, & Bioethics, also at Harvard Law School. He is also a Member of the CURE Drug Repurposing Collaboratory, which is a public-private partnership under the auspices of the Critical Path Institute (C-Path), in partnership with the U.S. Food and Drug Administration (FDA), and the National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health (NIH). David’s current research at Petrie-Flom focuses on identifying and addressing the legal, ethical, and practical challenges involved in home-based diagnostic and monitoring technology. He is also working on projects related to drug and device regulation and innovation; the philosophy of intellectual property; and “law.” His research has been published, or is forthcoming, in a variety of legal and medical publications, including the Boston College Law Review, the Emory Law Journal, the Florida Law Review, the Georgia Law Review, the Journal of Law & the Biosciences, the Journal of Law, Medicine, & Ethics, Nature Medicine, the Washington Law Review, the William & Mary Law Review, and the Yale Journal of Law & Technology.
Previously, David taught at The George Washington University Law School, the University of Kansas School of Law, and the Hanken School of Economics in Helsinki, Finland. Before entering academia, David represented clients in corporate, business, real estate, and intellectual property transactions. His clients included hedge fund managers, investment firms, small businesses, physicians, professional athletes, homeless veterans, singers, songwriters, and artists. He also served as a volunteer attorney for Lawyers for the Creative Arts. He also served as a judicial law clerk to the Honorable Martin C. Ashman at the United States District Court for the Northern District of Illinois.
David holds an LL.M. from Harvard Law School, where he was a Summer Academic Fellow, and a Ph.D. from the University of Cambridge, where he was a Cambridge International Scholar (full tuition scholarship & stipend) and member of Trinity College. He earned his B.A., with high honors, from the University of Michigan, and his J.D., with high honors, from Chicago-Kent College of Law, where he was selected to the Moot Court Honor Society, Order of the Coif, and Dean’s List. During law school, he won several writing awards for work in constitutional law and intellectual property law.
- B.A. Political Science University of Michigan, 2005
- J.D. Chicago-Kent College of Law, 2008
- LL.M. Harvard Law School, 2011
- Ph.D. Law University of Cambridge, Trinity College, 2019
- David A. Simon, Off-Label Innovation, 56 Ga. L. Rev. 701 (2022).
- David A. Simon, Barbara J. Evans, Carmel Shachar & I. Glenn Cohen, Should Alexa diagnose Alzheimer’s?: Legal and ethical issues with at-home consumer devices, Cell Reps. Med (2022).
- Patrick R. Goold & David A. Simon, Lucky IP, 42 Oxford J. Legal Stud. 843 (2022).
- David A. Simon, Carmel Shachar & I. Glenn Cohen, At-home Diagnostics and Diagnostic Excellence: Devices vs General Wellness Products, 327 JAMA 523 (2022).